AMR vs Nigeria: Hepatitis B surface antigen (HBsAg) prevalence
AMR
0.0%
in 2024
Nigeria
2.7%
in 2024
AMR rank
7th
Nigeria rank
8th
Hepatitis B surface antigen (HBsAg) prevalence over time
- AMR
- Nigeria
How they compare
Nigeria currently reports 2.7% against 0.0% in AMR, a difference of 2.7%.
Across all 10 years both countries report, Nigeria has been ahead every year.
AMR ranks 7th and Nigeria ranks 8th of 7 groups.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AMR | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 3.7% | 3.7% | Nigeria |
| 2020s | 0.0% | 3.1% | 3.1% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, AMR or Nigeria?
- Nigeria, at 2.7% against 0.0% in AMR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between AMR and Nigeria?
- 2.7%, with Nigeria ahead.
- How many years of comparable data are there for AMR and Nigeria?
- 10 years are reported by both, from 2015 to 2024.
- How do AMR and Nigeria rank globally for hepatitis b surface antigen (hbsag) prevalence?
- AMR ranks 7th and Nigeria ranks 8th of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.